At IDE, Regulatory Affairs isn’t merely about regulatory compliance.
It’s about navigating the complex landscape of medical device regulatory requirements through an entrepreneurial lens.
How we do it
IDE Group provides structured regulatory affairs support across medical devices, digital health, and advanced healthcare technologies. Our team brings proven experience delivering products to market across major global jurisdictions, with exposure to more than 90 international markets.
We support organisations at every stage of growth, providing regulatory leadership that enables confident decision making, effective development programs, and successful market access.
IDE Group delivers regulatory affairs support that scales with your organisation. We work with founder‑led ventures seeking targeted regulatory guidance and with established enterprises requiring integrated, hands‑on regulatory delivery.
Engagements range from focused regulatory advisory support and second‑opinion reviews through to full regulatory execution, emergency remediation, and surge support for existing regulatory and development teams. We integrate seamlessly with internal functions to strengthen capability while maintaining continuity and ownership.
Early‑stage companies face high regulatory uncertainty with limited margin for error. IDE Group supports founders, boards, and executive teams by translating regulatory requirements into clear development, commercial, and investment decisions.
Engagements often focus on defining regulatory pathways aligned to funding milestones, commercial objectives, and investor expectations. We shape regulatory strategies and narratives that support effective communication with investors and partners, while establishing scalable regulatory foundations for future expansion.
Our approach positions regulatory strategy as a contributor to enterprise value rather than a source of constraint.
Early regulatory clarity reduces technical risk and commercial uncertainty. IDE Group conducts structured regulatory assessments to establish direction before major development, funding, or market entry commitments are made.
Regulatory landscaping provides early insight into device classification, risk positioning, and target market pathways, outlining the fundamental regulatory requirements for entry across priority jurisdictions.
Regulatory roadmapping builds on this foundation by defining jurisdictional sequencing based on commercial priorities and regulatory requirements such as evidence generation and documentation expectations.
As organisations move toward regulatory submission, a clear understanding of readiness is critical. IDE Group conducts regulatory readiness assessments covering quality systems, verification documentation, and technical files to identify gaps against regulatory expectations.
The outcome is a prioritised, risk‑based action plan that supports efficient regulatory progression and reduces avoidable delay or rework.
We recognise that regulatory strategy is essential for the commercial success of your medtech venture. That’s why we provide customised solutions to ensure compliance with evolving global regulations while keeping your business objectives at the forefront of our approach.
What sets us apart
Regulatory strategy embedded in product development: IDE Group embeds regulatory expertise directly into the product development process. Regulatory considerations inform design decisions, verification planning, and evidence generation from early concept through the entire product lifecycle.
Our regulatory specialists work alongside clinical, quality, and product development teams, supported by structured quality management systems that promote consistency across documentation, testing, and regulatory engagement.Regulatory submissions and authority engagement: IDE Group supports preparation and execution of regulatory submissions and formal engagement with regulatory authorities and notified bodies. This includes investigational testing pathways, device licence applications, and structured responses during regulatory review cycles.
We identify documentation and evidence requirements, including non clinical and clinical testing, and compile technical documentation and regulatory submission packages aligned across United States, European, and international regulatory frameworks.Medical devices, digital health, and advanced healthcare technologies: Regulatory strategy plays a central role in shaping product architecture and development sequencing. Early classification analysis, regulatory pathway definition, and jurisdictional planning align engineering and clinical activities with appropriate regulatory routes and evidence expectations.
For combination products and advanced technologies, IDE Group coordinates regulatory requirements across device and drug regulatory domains to support efficient technical review and long term market access.
